-+ 0.00%
-+ 0.00%
-+ 0.00%

LONGEVERON - LAROMESTROCEL MAINTAINS FAVORABLE SAFETY PROFILE WITH 644 PATIENTS TREATED

Reuters·09/16/2026 21:27:16

Please log in to view news